Roche to temporarily halt Tamiflu shipments to U.S.

Share this article:
Swiss pharma company Roche said today it has temporarily suspended shipments of the anti-viral drug Tamiflu to wholesalers and other private recipients in the U.S. to make sure enough treatments will be available to treat conventional cases of the flu this winter.
Roche said companies have been creating their own stockpiles for use by their employees in the event of a pandemic caused by avian flu.
"At the present time we do not have an avian influenza pandemic in the United States," George Abercrombie, president of the Roche's American subsidiary, said in a statement yesterday. "However, we need to make sure that people exposed to this year's seasonal flu virus will have access to Tamiflu."
Roche said it would resume shipments of the drug when more flu cases occur this winter.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.